Project Grant K01TW013202
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Rochester a Project Grant of $601,307 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective September 24, 2025, with completion targeted for June 30, 2030. This research initiative investigates the molecular mechanisms of programmed ribosomal frameshifting (PRF) in human immunodeficiency virus type 1 (HIV-1)...
- Federal Project Grant Award Summary New York University received a $352,497 Project Grant award from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective June 1, 2026 through May 31, 2031. The award supports the Malaria Reservoir Study (MRS) II, a research initiative designed to investigate strategies for reducing parasite diversity in Plasmodium falciparum populations to enhance malaria intervention effectiveness in...
- Federal Grant Award Summary The University of Rochester received a $415,250 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 7, 2025, with a completion date of June 30, 2027. The award supports investigator-initiated biomedical research focused on understanding the immunological mechanisms of viral respiratory infections, specifically examining how long-lived highly differentiated...
- Federal Grant Award Summary The University of Rochester received a $226,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025 through June 30, 2027. This award funds research investigating novel mechanisms of CD4-independent immunity against Pneumocystis pneumonia (PCP), a life-threatening fungal respiratory infection affecting immunocompromised patients. The...
- Federal Grant Award Summary The University of Rochester received a $264,250 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), with an award date of May 5, 2026 and ultimate completion date of April 30, 2028. This research initiative delivers fundamental neuroscience research focused on developing and validating precise opto- and chemo-genetic...
- Federal Grant Award Summary The University of Michigan received a $353,166 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), awarded March 1, 2026, with completion scheduled for February 29, 2028. The Zambian Cohort of Healthy Aging and Dementia (ZCHAD) Study will assess the prevalence rate of Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) and associated risk factors among adults age 55...
- Federal Grant Award Summary The University of Global Health Equity (UGHE) received a $131,278 Project Grant award from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective September 16, 2025, through August 31, 2030. This Emerging Global Leader (K43) career development award supports a clinician-researcher and faculty general surgeon at UGHE's Center for Equity in Global Surgery in advancing breast cancer care in Rwanda...
- Federal Grant Award Summary The University of Rochester received a $226,500 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for the period January 1, 2026 through December 31, 2027. This award funds research investigating the molecular mechanisms by which transmembrane AMPA receptor regulatory proteins (TARPs) modulate AMPA receptor gating, which are...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Massachusetts General Hospital $1.73 million through the Aging Research program (CFDA 93.866) on February 15, 2026, to conduct a four-year research project examining cognitive impairment and Alzheimer's Disease and Related Dementias (ADRDS) among people living with HIV (PWH) in Uganda. The project will deliver comprehensive neuropsychological assessments, brain imaging analysis, and plasma biomarker testing for 600 older...
- Federal Grant Award Summary The University of Rochester received a $156,555 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for a five-year research period commencing May 1, 2026 and concluding April 30, 2031. The grant supports basic neuroscience research investigating dopaminergic system dysfunction in neurodevelopmental disorders, with specific focus on leveraging adolescent brain plasticity mechanisms to...
The University of Rochester received a $908,204 Project Grant award from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective June 1, 2026 through May 31, 2030. This International Research Scientist Development Award (K-Award) supports mentored research and career development training to advance expertise in translating global health findings for U.S. populations and underserved healthcare systems. The research program will validate neurocognitive impairment (NI) screening tools and analyze inflammatory biomarkers predictive of NI in meningitis patients with and without HIV in rural northern Uganda, an area with high meningitis burden within Africa's meningitis belt. The award delivers two primary research objectives: (1) validation of neurocognitive assessment tools to determine NI burden among meningitis patients with and without HIV, including two-year follow-up to assess long- and short-term morbidity outcomes, and (2) identification of clinical parameters and immune/inflammatory biomarkers predictive of NI through collection and analysis of serum and cerebrospinal fluid samples. Research activities are embedded within an existing Meningitis Diagnosis and Treatment Program at Lira Regional Referral Hospital in northern Uganda. This initiative addresses significant gaps in understanding NI burden and pathogenesis in meningitis populations, where 14-38% of survivors develop prolonged neurocognitive impairment despite limited data characterizing brain injury biomarkers associated with NI development.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $908.2k | 6/3/26 |